Detection of 1p19q Deletion by Real-Time Comparative Quantitative PCR
Open Access
- 1 January 2012
- journal article
- Published by SAGE Publications in Biomarker Insights
- Vol. 7, BMI.S9003-17
- https://doi.org/10.4137/bmi.s9003
Abstract
1p/19q (1p and/or 19q) deletions are prognostic factors in oligodendroglial tumors (OT) and predict better survival after both chemotherapy and radiotherapy. While studying 1p/19q status as a potential variable within multivariate prognosis models for OT, we have frequently encountered unknown 1p/19q status within our glioma sample database due to lack of paired blood samples for loss of heterozygosity (LOH) assay and/or failure to perform fluorescence in situ hybridization (FISH). We realized that a 1p and 19q deletion assay that could be reliably performed solely on tumor DNA samples would allow us to fill in these molecular biology data “holes”. We built recombinant DNA with fragments of the selected “marker” genes in 1p (E2F2, NOTCH2), and 19q (PLAUR) and “reference” genes (ERC2, SPOCK1, and SPAG16) and used it as quantification standard in real-time PCR to gain absolute ratios of marker/reference gene copy numbers in tumor DNA samples, thus called comparative quantitative PCR (CQ-PCR). Using CQ-PCR, we identified 1p and/or 19q deletions in majority of pure low-grade oligodenroglioma (OG) tumors (17/21, 81%), a large portion of anaplastic oligodendro% of mixed oligodendroglioma (AO) tumors (6/15, 47%), but rarely found in mixed oligoastrcytomas (OA) tumors (1/8, 13%). These data are consistent with results of LOH and FISH assays generally reported for these tumor types. In addition, 15 out 18 samples showed concordant results between FISH and CQ-PCR. We conclude that CQ-PCR is a potential means to gain 1p/19q deletion information, which prognostic and predictive values of CQ-PCR-derived 1p/19q status will be determined in a future study.Keywords
This publication has 32 references indexed in Scilit:
- International retrospective study of over 1000 adults with anaplastic oligodendroglial tumorsNeuro-Oncology, 2011
- Establishment of Prognostic Models for Astrocytic and Oligodendroglial Brain Tumors with Standardized Quantification of Marker Gene Expression and Clinical VariablesBiomarker Insights, 2010
- Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain TumorsPLOS ONE, 2007
- Multiplex Ligation-Dependent Probe Amplification: A Diagnostic Tool for Simultaneous Identification of Different Genetic Markers in Glial TumorsThe Journal of Molecular Diagnostics, 2006
- Subtyping of oligo-astrocytic tumours by comparative genomic hybridizationThe Journal of Pathology, 2001
- Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction AssayThe American Journal of Pathology, 2001
- Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeOncogene, 1999
- Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the gradeGenes, Chromosomes and Cancer, 1998
- Molecular analysis of chromosomh 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumorsInternational Journal of Cancer, 1994
- Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomasGenes, Chromosomes and Cancer, 1992